`
`Apotex Corp. A Global Leader Focused on Excellence
`
`Sign up for the PharmacyTimes Newsletter
`
`Clinical
`Resources
`
`Videos
`
`Publications
`
`Contributors
`
`SHOWING CONTENT FOR:
`Community Pharmacist ▼
`Conference
`Continuing
`Coverage
`Education
`
` Search
`
` Login
`
`Back to issue
`Apotex Corp. A Global Leader Focused on
`Excellence
`
`JULY 11, 2014
`
`
`Apotex Corp., headquartered in Weston, Florida, is the US subsidiary of Apotex Inc., the largest
`Canadian-owned pharmaceutical company. Apotex Inc. produces more than 780 generic
`pharmaceutical products in approximately 2300 SKUs and exports to 121 countries globally. The
`company has successfully secured FDA approval for over 250 ANDAs—with another 375 currently in
`active development.
`
`Apotex Corp. is frequently recognized for outstanding service by customers and is ranked in the top 10
`generic pharmaceutical manufacturers according to recent IMS Health data. Apotex’s expansive
`product portfolio spans a wide range of dosage forms and therapeutic classes, including
`cardiovascular, anti-infectives, gastrointestinal, central nervous system, mental health, pain
`management, and respiratory. The company continues to diversify its product mix by adding new
`therapeutic areas and dosage forms such as transdermal patches and injectables. Earlier this year,
`Apotex launched several new products, including 2 first-tomarket generics—Budesonide Nasal Spray
`(generic equivalent to Rhinocort Aqua®) and Diclofenac Topical Solution (generic equivalent to
`Pennsaid®). With a number of first-to-file submissions and first-to-file market launches in our pipeline,
`Apotex is well positioned for growth.
`
`Commitment to Quality and Global Supply Chain Efficiencies
`
`Apotex’s highest priority is its Global Quality Program, which it considers integral to maintaining its
`strategic industry relationships. Over the past 4 years, Apotex has invested up to $150 million in new
`quality systems, technologies, and new software solutions. “Quality is something that we can never
`say we’ve done—it’s a continuous journey,” says Jeremy Desai, president and COO of Apotex Inc.
`“We have the advantage of being vertically integrated, and a large percentage of products we develop,
`we manufacture the pharmaceutical ingredient—the API,” says Desai.
`
`Investing for Tomorrow
`
`New generic products are a critical component of Apotex’s growth. Apotex has historically reinvested
`close to 20% of its revenues in research and development. More importantly, Apotex is focused on
`more than simply developing new generics; the company is also working actively to develop a broad
`portfolio of biosimilars.
`
`According to Desai, “Apotex is being built on a vision that is to provide affordable health care to
`patients across the globe.” Deeply entrenched in the company’s culture is the ability to adapt quickly
`by staying relevant in the changing health care industry landscape.
`
`Reliable Advocate and Trusted Partner
`
`Among generic manufacturers, Apotex stands alone in opposing anticompetitive patent settlements
`that delay generic competition, both by litigating against them and in advocating against them to the
`Federal Trade Commission and to Congress.
`
`IMPORTANT SAFETY INFORMATION
`CONTRAINDICATIONS
`BASAGLAR is contraindicated during episodes of
`hypoglycemia, and in patients with hypersensitivity to insulin
`glargine or one of its excipients.
`WARNINGS AND PRECAUTIONS
`BASAGLAR KwikPen® must never be shared between patients,
`The Power of One: How Partnering Can
`Enhance Your Independent Brand
`
`The Mom and Pops and stand-alones out there
`need to come together and form an alliance.
`
`ketoacidosis.
`IMPORTANT SAFETY INFORMATION
`CONTRAINDICATIONS
`BASAGLAR is contraindicated during episodes of
`hypoglycemia, and in patients with hypersensitivity to insulin
`glargine or one of its excipients.
`WARNINGS AND PRECAUTIONS
`
`Pharmacist Education
`
`Clinical features with downloadable PDFs
`
`Apotex believes that all manufacturers have a corporate citizenship responsibility to the global
`community. The company performs this responsibility through various national initiatives and
`partnerships. Apotex provides educational support to pharmacy students through a partnership with
`the National Community Pharmacists Association Foundation and supports the NACDS Foundation
`Pharmacy Partners Scholarship Program through a $1 million donation. Apotex continues to donate
`
`Exhibit 1103
`IPR2017-00807
`ARGENTUM
`http://www.pharmacytimes.com/publications/supplement/2014/generic-supplement-2014/apotex-corp-a-global-leader-focused-on-excellence
`1/3
`
`000001
`
`
`
`Apotex Corp. A Global Leader Focused on Excellence
`1/25/2018
`lifesaving medicines to developing countries to alleviate human suffering and save the lives of
`thousands of people. Apotex is committed to serving the global community by providing the highest
`quality of affordable generic medicines.
`
`For more information, visit www.apotexcorp.com.
`
`
` SHARE THIS
`
`◄
`
`0
`
` RELATED COVERAGE
`
`Clinical Use of Generic
`Injectable Drugs in
`Hospitalized Patients
`
`Generic Product News
`(September 2017)
`
`Generic Product News
`(August 2017)
`
` YOU MAY ALSO BE INTERESTED IN
`
`Clinical Use of Generic
`Injectable Drugs in
`Hospitalized Patients
`
`Generic Product News
`(September 2017)
`
`Generic Product News
`(August 2017)
`
`SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
`Personalize the information you receive by selecting targeted content and special offers.
`
`Enter your email address
`
`Sign Up
`
`RELATED SITES
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`About Pharmacy Times
`Pharmacy Times® is the #1 full-service pharmacy media resource in the
`industry. Founded in 1897, Pharmacy Times® reaches a network of over
`1.3 million retail pharmacists. Through our print, digital and live events
`channels, Pharmacy Times® provides clinically based, practical and timely
`information for the practicing pharmacist. Features and specialized
`departments cover medication errors, drug interactions, patient education,
`pharmacy technology, disease state management, patient counseling,
`product news, pharmacy law and health-system pharmacy. Pharmacy
`Times Continuing Education™ (PTCE) is accredited by the Accreditation
`Council for Pharmacy Education (ACPE) as a provider of continuing
`pharmacy education.
`
`
`
`Pharmacy & Healthcare Communications, LLC
`
`2 Clarke Drive
`
`Suite 100
`
`Cranbury, NJ 08512
`P: 609-716-7777
`
`F: 609-716-9038
`
`
`
`
`Careers Contact Us Feedback Advertise With Us Terms & Conditions Privacy Press Room
`http://www.pharmacytimes.com/publications/supplement/2014/generic-supplement-2014/apotex-corp-a-global-leader-focused-on-excellence
`
`2/3
`
`000002
`
`
`
`1/25/2018
`
`Apotex Corp. A Global Leader Focused on Excellence
`
`Copyright © 2006-2017 Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
`
`http://www.pharmacytimes.com/publications/supplement/2014/generic-supplement-2014/apotex-corp-a-global-leader-focused-on-excellence
`
`3/3
`
`000003
`
`